Complicated Bacteroides peritonitis

Complicated *Bacteroides* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, driven primarily or as part of a polymicrobial process by anaerobic species of the genus *Bacteroides* (most notably *Bacteroides fragilis*) Clinically and pathophysiologically, it is defined by localized abscess formation or diffuse peritonitis, purulent peritoneal exudates, capsular polysaccharide–me...

Complicated *Bacteroides* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, driven primarily or as part of a polymicrobial process by anaerobic species of the genus *Bacteroides* (most notably *Bacteroides fragilis*) Affecting adult and pediatric patients typically following gastrointestinal mucosal disruption, perforation, or trauma, this condition involves bacterial transloc...

Complicated *Bacteroides* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, driven primarily or as part of a polymicrobial process by anaerobic species of the genus *Bacteroides* (most notably *Bacteroides fragilis*) Affecting adult and pediatric patients typically following gastrointestinal mucosal disruption, perforation, or trauma, this condition involves bacterial transloc...

Affecting adult and pediatric patients typically following gastrointestinal mucosal disruption, perforation, or trauma, this condition involves bacterial translocation into normally sterile peritoneal spaces

Clinically and pathophysiologically, it is defined by localized abscess formation or diffuse peritonitis, purulent peritoneal exudates, capsular polysaccharide–mediated host immune responses, and peritoneal signs such as severe abdominal pain, rigidity, and systemic toxicity that frequently require procedural source control alongside targeted antimicrobial therapy